Anti-VEGF therapy: a new approach to colorectal cancer therapy.
about
Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levelsThe effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.Capecitabine plus oxaliplatin for the treatment of colorectal cancer.Anti-angiogenic effect of total saponins of Rhizoma Dioscorea nipponica on collagen induced-arthritis in rats.
P2860
Anti-VEGF therapy: a new approach to colorectal cancer therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Anti-VEGF therapy: a new approach to colorectal cancer therapy.
@ast
Anti-VEGF therapy: a new approach to colorectal cancer therapy.
@en
type
label
Anti-VEGF therapy: a new approach to colorectal cancer therapy.
@ast
Anti-VEGF therapy: a new approach to colorectal cancer therapy.
@en
prefLabel
Anti-VEGF therapy: a new approach to colorectal cancer therapy.
@ast
Anti-VEGF therapy: a new approach to colorectal cancer therapy.
@en
P2093
P2860
P1476
Anti-VEGF therapy: a new approach to colorectal cancer therapy.
@en
P2093
Alfredo Carrato
Carmen Guillen-Ponce
Javier Gallego-Plazas
P2860
P304
P356
10.1586/14737140.6.10.1385
P577
2006-10-01T00:00:00Z